Dosage Form: ointment
Medically reviewed on Jun 1, 2018
Nystatin Ointment Description
Nystatin Ointment - Clinical Pharmacology
Nystatin is an antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi, including Candida albicans, C.parapsilosis, C.tropicalis, C.guilliermondi, C. pseudotropicalis, C. krusei, Torulopsis glabrata, Tricophyton rubrum, T. mentagrophytes.
Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing concentrations of nystatin, Candida albicans does not develop resistance to nystatin. Generally, resistance to nystatin does not develop during therapy. However, other species of Candida (C. tropicalis, C. guilliermondi, C. krusei, and C. stellatoides) become quite resistant on treatment with nystatin and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed.
Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.
Indications and Usage for Nystatin Ointment
Nystatin Ointment is not indicated for systemic, oral, intravaginal or ophthalmic use.
If irritation or sensitization develops, treatment should be discontinued and appropriate measures taken as indicated. It is recommended that KOH smears, cultures, or other diagnostic methods be used to confirm the diagnosis of cutaneous or mucocutaneous candidiasis and to rule out infection caused by other pathogens.
INFORMATION FOR PATIENTS
- The patient should be instructed to use these medications as directed (including the replacement of missed doses). These medications are not for any disorder other than that for which they are prescribed.
- Even if symptomatic relief occurs within the first few days of treatment, the patient should be advised not to interrupt or discontinue therapy until the prescribed course of treatment is completed.
- If symptoms of irritation develop, the patient should be advised to notify the physician promptly
Carcinogenesis, Mutagenesis, Impairment of Fertility
No long-term animal studies have been performed to evaluate the carcinogenic potential of nystatin. No studies have been performed to determine the mutagenicity of nystatin or its effects on male or female fertility.
Pregnancy: Teratogenic Effects
Category C. Animal reproduction studies have not been conducted with any nystatin topical preparation. It also is not known whether these preparations can cause fetal harm when used by a pregnant woman or can affect reproductive capacity. Nystatin topical preparations should be prescribed for a pregnant woman only if the potential benefit to the mother outweighs the potential risk to the fetus.
See DOSAGE AND ADMINISTRATION
The frequency of adverse events reported in patients using Nystatin Ointment preparations is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application.
(See PRECAUTIONS: General.)
Nystatin Ointment Dosage and Administration
Adults and Pediatric Patients (Neonates and Older):
Apply liberally to affected areas twice daily or as indicated until healing is complete.
How is Nystatin Ointment Supplied
NDC 68382-333-01 in tube of 15 gm
NDC 68382-333-02 in tube of 30 gm
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Cadila Healthcare Limited
Changodar, Ahmedabad, India.
Zydus Pharmaceuticals (USA) Inc.
Pennington, NJ 08534
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Nystatin Ointment USP, 15 g
|Labeler - Zydus Pharmaceuticals (USA) Inc. (156861945)|
|Registrant - Zydus Pharmaceuticals (USA) Inc. (156861945)|
|Cadila Healthcare Limited||650650802||ANALYSIS(68382-333), MANUFACTURE(68382-333)|
More about nystatin topical
- Nystatin topical Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Compare Alternatives
- Pricing & Coupons
- En Español
- 14 Reviews
- Drug class: topical antifungals
- Nystatin (AHFS Monograph)
- Nystatin Cream (FDA)
- Nystatin Powder (FDA)
- Nystatin (Topical) (Wolters Kluwer)